The covalent functionalization of graphene oxide (GO) with chitosan (CS) is successfully accomplished via a facile amidation process. The CS-grafted GO (GO-CS) sheets consist of about 64 wt.% CS, which imparts them with a good aqueous solubility and biocompatibility. Additionally, the physicochemical properties of GO-CS are studied. As a novel nanocarrier, GO-CS is applied to load a water-insoluble anticancer drug, camptothecin (CPT), via π-π stacking and hydrophobic interactions. It is demonstrated that GO-CS possesses a superior loading capacity for CPT, and the GO-CS-CPT complexes show remarkably high cytotoxicity in HepG2 and HeLa cell lines compared to the pure drug. At the same time, GO-CS is also able to condense plasmid DNA into stable, nanosized complexes, and the resulting GO-CS/pDNA nanoparticles exhibit reasonable transfection efficiency in HeLa cells at certain nitrogen/phosphate ratios. Therefore, the GO-CS nanocarrier is able to load and deliver both anticancer drugs and genes.

Covalently functionalized graphene sheets are prepared by grafting a welldefi ned thermo-responsive poly( N -isopropylacrylamide) (PNIPAM) via click chemistry. The PNIPAM-grafted graphene sheets (PNIPAM-GS) consist of about 50% polymer, which endows the sheets with a good solubility and stability in physiological solutions. The PNIPAM-GS exhibits a hydrophilic to hydrophobic phase transition at 33 ° C, which is relatively lower than that of a PNIPAM homopolymer because of the interaction between graphene sheets and grafted PNIPAM. Moreover, through π --π stacking and hydrophobic interaction between PNIPAM-GS and an aromatic drug, the PNIPAM-GS is able to load a water-insoluble anticancer drug, camptothecin (CPT), with a superior loading capacity of 15.6 wt-% (0.185 g CPT per g PNIPAM-GS). The in vitro drug release behavior of the PNIPAM-GS-CPT complex is examined both in water and PBS at 37 ° C. More importantly, the PNIPAM-GS does not exhibit a practical toxicity and the PNIPAM-GS-CPT complex shows a high potency of killing cancer cells in vitro. The PNIPAM-GS is demonstrated to be an effective vehicle for anticancer drug delivery.

ObjectivesThe purpose of this study is to assess the prevalence of overweight/obesity, abdominal obesity and obesity-related risk factors in southern China.MethodsA cross-sectional survey of 15,364 participants aged 15 years and older was conducted from November 2013 to August 2014 in Jiangxi Province, China, using questionnaire forms and physical measurements. The physical measurements included body height, weight, waist circumference (WC), body fat percentage (BFP) and visceral adipose index (VAI). Multivariate logistic regression analysis was performed to evaluate the risk factors for overweight/obesity and abdominal obesity.ResultsThe prevalence of overweight was 25.8% (25.9% in males and 25.7% in females), while that of obesity was 7.9% (8.4% in males and 7.6% in females). The prevalence of abdominal obesity was 10.2% (8.6% in males and 11.3% in females). The prevalence of overweight/obesity was 37.1% in urban residents and 30.2% in rural residents, and this difference was significant (P < 0.001). Urban residents had a significantly higher prevalence of abdominal obesity than rural residents (11.6% vs 8.7%, P < 0.001). Among the participants with an underweight/normal body mass index (BMI), 1.3% still had abdominal obesity, 16.1% had a high BFP and 1.0% had a high VAI. Moreover, among obese participants, 9.7% had a low /normal WC, 0.8% had a normal BFP and 15.9% had a normal VAI. Meanwhile, the partial correlation analysis indicated that the correlation coefficients between VAI and BMI, VAI and WC, and BMI and WC were 0.700, 0.666, and 0.721, respectively. A multivariate logistic regression analysis indicated that being female and having a high BFP and a high VAI were significantly associated with an increased risk of overweight/obesity and abdominal obesity. In addition, living in an urban area and older age correlated with overweight/obesity.ConclusionThis study revealed that obesity and abdominal obesity, which differed by gender and age, are epidemic in southern China. Moreover, there was a very high, significant, positive correlation between WC, BMI and VAI. However, further studies are needed to explore which indicator of body fat could be used as the best marker to indirectly reflect cardiometabolic risk.

We present a novel approach to the fabrication of advanced polymeric nanocomposites from poly(vinyl alcohol) (PVA) by incorporation of PVA-grafted graphene oxide. In this work, we have synthesized PVA-grafted graphene oxide (PVA-g-GO) for the strong interfacial adhesion of graphene oxide (GO) to the PVA matrix. It was found that the mechanical properties of PVA were greatly improved by incorporating PVA-g-GO. For example, the tensile strength and Young's modulus of the PVA nanocomposite films containing 1 wt % net GO in the PVA-g-GO significantly increased by 88 and 150%, respectively, as compared to unfilled PVA. The elongation at break was also increased by 22%, whereas the GO/PVA nanocomposite containing 1 wt % pristine GO was decreased by 15%. Therefore, the presence of the PVA-g-GO in the PVA matrix could make the PVA not only stronger but also tougher. The strong interfacial adhesion between PVA-g-GO and the PVA matrix was attributed to the good compatibility between PVA-g-GO and the matrix PVA as well as the hydrogen-bonding between them.

Carbon nanomaterials such as multiwalled carbon nanotubes (MWCNTs) and graphene oxide (GO) have been functionalized by highly hydrophilic and biocompatible poly(vinyl alcohol) (PVA) for loading and delivery of an anticancer drug, camptothecin (CPT). For the first time, CPT was loaded onto MWCNT-PVA and GO-PVA through π-π interactions and its capability to kill human breast and skin cancer cells was investigated.